THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE

罗格列酮在调节 HDL 胆固醇的作用

• 批准号: 7607475
• 负责人: Annabelle Rodriguez
• 金额: $ 0.03万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607475
• 关键词: Cholesterol; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; High Density Lipoprotein Cholesterol; Institution; Purpose; Research; Research Personnel; Resources; Role; Source; United States National Institutes of Health; rosiglitazone

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is understand how rosiglitazone modulates HDL cholesterol levels.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是了解罗格列酮如何调节高密度脂蛋白胆固醇水平。